Laird Norton Wetherby Wealth Management, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Laird Norton Wetherby Wealth Management, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$447,590
-1.4%
11,717
-6.9%
0.02%
+4.2%
Q2 2023$453,797
+7.0%
12,581
+13.2%
0.02%
-4.0%
Q1 2023$424,291
-34.9%
11,110
-2.9%
0.02%
-40.5%
Q4 2022$651,334
+34.0%
11,447
-6.8%
0.04%
+23.5%
Q3 2022$486,000
-19.8%
12,284
-10.8%
0.03%
-17.1%
Q2 2022$606,000
+9.0%
13,775
-1.2%
0.04%
+28.1%
Q1 2022$556,000
-0.7%
13,949
+0.1%
0.03%
+3.2%
Q4 2021$560,000
-1.6%
13,931
-0.4%
0.03%
-11.4%
Q3 2021$569,000
-10.8%
13,988
-0.5%
0.04%
-10.3%
Q2 2021$638,000
-7.1%
14,052
-12.7%
0.04%
-17.0%
Q4 2020$687,00016,0950.05%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders